Incyte

@Incyte

Incyte’s official Twitter. Ready to Solve On. See our Community Guidelines: bit.ly/2sV0H5W

Wilmington, DE

Incyte
@Incyte
Aug 10
We're attending the @nbd_foundation's 78th Annual Bleeding Disorders Conference (BDC) in Orlando, August 13–15. Our team is excited to listen to, learn from and connect with the bleeding disorders community. #BDC2026
00:00
Incyte
@Incyte
Jul 29
Patients guide our work in dermatology. Hervé Lamarque, Division Vice President, Head of Business Unit Inflammation & Autoimmunity (IAI) International, shares how Incyte’s commitment to the global dermatology community helps shape our research and innovation.
00:00
Incyte
@Incyte
Jul 29
Atopic dermatitis (AD) is a chronic inflammatory skin disease that can affect daily life. Learn more about AD and our commitment to patients. bit.ly/44VPJvQ
00:00
Incyte
@Incyte
Jul 29
Incyte announces @EU_Commission approval of our topical JAK treatment for adults with moderate atopic dermatitis. Read to learn more. bit.ly/4ftTxul
00:00
Incyte
@Incyte
Jul 28
Read our press release to learn more about Incyte’s Q2 financial results and business updates. bit.ly/4hkgZLZ
00:00